Post
Form appears to be treating enormous industrial-execution risk as though sufficiently elegant chemistry and sufficient capital will eventually solve it. It has raised more than $2 billion in equity, including $750 million last month, yet its latest round valued the company at $1.75 billion before the new money - down from $3 billion in 2024. Investors have now put more into Form than the market believed the entire company was worth before this raise. For all that capital, Form is only beginning commercial production. Its first factory employs roughly 400 people and is targeting 500 MW of annual production capacity by 2028. Against that, management has already accumulated an 80 GWh backlog, up from 20 GWh at the beginning of the year. The promise of scale is running far ahead of demonstrated manufacturing. There is still no publicly available accelerated-aging study - by Form or an independent laboratory - showing that the production unit being scaled will deliver anything approaching a 30-year economic life. What the company shows publicly still has the character of a college laboratory: exposed tubing, hand-marked cells and heavily instrumented test assemblies. Form also continues working through relatively minor electrochemical questions when the central risk has moved elsewhere. As Musk has observed, designing the product is perhaps 10% of the problem. Manufacturing...
Keep reading with a free account
The rest of this post, and every signal for Northvolt, is in your free account.
Extracted from these lines
The chemistry can work and the company can still become insolvent. Northvolt managed that with proven lithium-ion technology.
From the post